Unaltered Plasma Levels of β-Amyloid(1–40) and β-Amyloid(1–42) upon Stimulation of Human Platelets

Publisher： Karger

E-ISSN： 1421-9824|16|2|93-97

ISSN： 1420-8008

Source： Dementia and Geriatric Cognitive Disorders, Vol.16, Iss.2, 2003-06, pp. : 93-97

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Increase in β-Amyloid Levels in Cerebrospinal Fluid of Children with Down Syndrome

By  

Dementia and Geriatric Cognitive Disorders, Vol. 24, Iss. 5, 2007-10 ,pp. : 369-374

Karger

Access to resources Recommend Favorite

Stability of CSF β-Amyloid1–42 and Tau Levels by APOE Genotype in Alzheimer Patients

By  

Dementia and Geriatric Cognitive Disorders, Vol. 22, Iss. 1, 2006-06 ,pp. : 48-53

Karger

Access to resources Recommend Favorite

β-Amyloid (1–42) Levels in Cerebrospinal Fluid and Cerebral Atrophy in Mild Cognitive Impairment and Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders Extra, Vol. 1, Iss. 1, 2011-11 ,pp. : 393-401

Karger

Access to resources Recommend Favorite

Progression of Mild Cognitive Impairment to Alzheimer’s Disease: Improved Diagnostic Value of the Combined Use of N200 Latency and β-Amyloid(1–42) Levels

By  

Dementia and Geriatric Cognitive Disorders, Vol. 28, Iss. 1, 2009-07 ,pp. : 30-35

Karger

Access to resources Recommend Favorite

CSF Biomarkers for Alzheimer’s Disease: Levels of β-Amyloid, Tau, Phosphorylated Tau Relate to Clinical Symptoms and Survival

By  

Dementia and Geriatric Cognitive Disorders, Vol. 21, Iss. 3, 2006-02 ,pp. : 131-138

Karger

Access to resources Recommend Favorite